Cetylpyridinium chloride inhibits the polarization of tumor-associated macrophages and the proliferation of triple-negative breast cancer cells

Key Points

• Cetylpyridinium chloride inhibits the polarization of tumor-associated macrophages, subsequently reducing cancer cell proliferation.
• The analysis shows a significant decrease in proliferative rates, particularly in triple-negative breast cancer cells.
• Testing utilized both in vitro and in vivo models, focusing on cellular interactions and macrophage behavior.
• The findings highlight the potential for cetylpyridinium chloride as a therapeutic option, although further studies are required.